Drug Profile

EVP 0962

Alternative Names: EVP-0015962; EVP-0962

Latest Information Update: 25 Nov 2016

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator EnVivo Pharmaceuticals
Developer FORUM Pharmaceuticals
Class Nootropics; Small molecules
Mechanism of Action Amyloid precursor protein secretase modulators

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity Yes

Highest Development Phases

Discontinued Alzheimer's disease

Most Recent Events

01 Jun 2016 Discontinued - Phase-II for Alzheimer's disease in USA (PO)
03 Oct 2015 No recent reports of development identified - Phase-II for Alzheimer's disease in USA (PO)
02 Apr 2014 EnVivo Pharmaceuticals is now called FORUM Pharmaceuticals

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com